Your browser doesn't support javascript.
loading
Anti-idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
Ogiwara, Kenichi; Furukawa, Shoko; Shinohara, Sho; Tabuchi, Yuka; Arai, Nobuo; Noguchi-Sasaki, Mariko; Soeda, Tetsuhiro; Shima, Midori; Nogami, Keiji.
Affiliation
  • Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Furukawa S; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Shinohara S; Reagent Engineering, Sysmex Corporation, Kobe, Japan.
  • Tabuchi Y; System Engineering, Sysmex Corporation, Kobe, Japan.
  • Arai N; Reagent Engineering, Sysmex Corporation, Kobe, Japan.
  • Noguchi-Sasaki M; Chugai Pharmaceutical Co., Research Division, Gotemba, Japan.
  • Soeda T; Chugai Pharmaceutical Co., Research Division, Gotemba, Japan.
  • Shima M; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Nogami K; The Center of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara, Japan.
Haemophilia ; 29(1): 329-335, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36137299
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Japan